“…The diagnosis of nasopharyngeal carcinoma is based on a maintained high-level clinical suspicion and is obtained with clinical (ear, nose, and throat) and fiberoptic examination, and appropriate radiological imaging: CT and magnetic resonance imaging scans are complementary for the initial screening, whereas PET technique proves more effective for the clinical follow-up and the early detection of eventual relapses. 6,12 However, a prompt local biopsy is mandatory to examine the histopathologic picture and to J INT ASSOC PHYSICIANS AIDS CARE 6(4); 2007 study eventual cell transformation, 5,[12][13][14][15] as well as to detect the presence of EBV genoma, 1,6,10,12 as mentioned above. In an immunocompromised host or among HIV-infected patients, the differential diagnosis of nasopharyngeal carcinoma has to take into account a broad spectrum of bacterial, fungal, mycobacterial, and other opportunistic infections, and lymphoma and other malignancies too, 12,16,17 while a concomitant, EBV-associated lymphatic hypertrophy of surrounding tissues may be more frequent just in patients with HIV disease, to mimic a lymphoproliferative disease.…”